Hillsborough, NJ, United States of America

Matthew Michael Kreilein



 

Average Co-Inventor Count = 7.9

ph-index = 4

Forward Citations = 65(Granted Patents)


Location History:

  • Watchung, NJ (US) (2013 - 2016)
  • Hilsborough, NJ (US) (2016)
  • Hillsborough, NJ (US) (2015 - 2020)

Company Filing History:


Years Active: 2013-2020

Loading Chart...
Loading Chart...
Loading Chart...
18 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Matthew Michael Kreilein

Introduction

Matthew Michael Kreilein is a prominent inventor based in Hillsborough, NJ (US). He has made significant contributions to the field of pharmaceuticals, holding a total of 18 patents. His work primarily focuses on developing inhibitors for specific enzymes that play a crucial role in various diseases.

Latest Patents

Kreilein's latest patents include compositions comprising an inhibitor of lysine specific demethylase-1. These patents describe both amorphous and crystalline forms of pharmaceutically acceptable salts of the lysine specific demethylase-1 inhibitor 4-[2-(4-aminopiperidin-1-yl)-5-(3-fluoro-4-methoxy-phenyl)-1-methyl-6-oxo-1,6-dihydropyrimidin-4-yl]-2-fluorobenzonitrile. Additionally, he has developed pharmaceutical compositions suitable for administration to mammals, which include the lysine specific demethylase-1 inhibitor. These compositions are intended for treating diseases or conditions associated with lysine specific demethylase-1 activity. Another notable patent involves processes for the preparation of cis-4-[2-{[(3S,4R)-3-fluorooxan-4-yl]amino}-8-(2,4,6-trichloroanilino)-9H-purin-9-yl]-1-methylcyclohexane-1-carboxamide.

Career Highlights

Throughout his career, Kreilein has worked with several notable companies, including Signal Pharmaceuticals, Inc. and Celgene Corporation. His experience in these organizations has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry.

Collaborations

Kreilein has collaborated with various professionals in his field, including Juan Antonio Gamboa and Benjamin Cohen. These collaborations have further enhanced his innovative work and expanded the impact of his inventions.

Conclusion

Matthew Michael Kreilein is a distinguished inventor whose work in pharmaceutical innovations has led to numerous patents and advancements in medical treatments. His contributions continue to influence the field and improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…